CryoLife, an Atlanta-based company that provides implantable human tissue for cardiac and vascular surgeries, said its board of directors has increased the company’s quarterly dividend 10 percent from .025 cents to .0275 cents.
The dividend is payable June 21 to common shareholders of record as of June 14. The ex-dividend date for the quarterly dividend is June 12.
Based on the number of shares currently outstanding, CryoLife expects to pay about $3 million in dividends this year.
On the New York Stock Exchange, CryoLife’s shares traded more than 2 percent higher early Tuesday at $6.43.
About the Author
Keep Reading
The Latest
